Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals.
AL-Nahhas
Adil
A
Department of Nuclear Medicine, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. aal-nahhas@hhnt.org
D002986:Clinical Trials as Topic; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007457:Iodine Radioisotopes; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D017556:Technetium Compounds; D013793:Thallium; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging*
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D017556:Technetium Compounds; D019788:Fluorodeoxyglucose F18; C027549:thallium chloride; D013793:Thallium